Christopher Tinkle

14PUBLICATIONS
67CO-AUTHORS
Radiation therapyGene expression (incl. microarray and other genome-wide approaches)Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Nov 03, 2026
Feasibility and Tolerability of Chemoimmunotherapy Given During Induction for Treatment of Patients With High-Risk Neuroblastoma: A Report From the Children's Oncology Group.

|Jun 15, 2023
Correlation between Multiparametric MR Imaging and Molecular Genetics in Pontine Pediatric High-Grade Glioma.

V Rameh, S Vajapeyam, A Ziaei

|Mar 27, 2023
ATM inhibition enhances the efficacy of radiation across distinct molecular subgroups of pediatric high-grade glioma.

Jia Xie, Teneema Kuriakose, Brandon Bianski

|Sep 20, 2022
Response assessment in pediatric craniopharyngioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) Working Group.

Lindsey M Hoffman, Camilo Jaimes, Kshitij Mankad

|Jan 07, 2022
Phase I study using crenolanib to target PDGFR kinase in children and young adults with newly diagnosed DIPG or recurrent high-grade glioma, including DIPG.

Christopher L Tinkle, Alberto Broniscer, Jason Chiang

|Dec 11, 2021
Revised clinical and molecular risk strata define the incidence and pattern of failure in medulloblastoma following risk-adapted radiotherapy and dose-intensive chemotherapy: results from a phase III multi-institutional study.

John T Lucas, Christopher L Tinkle, Jie Huang

Pageof 3

Frequent Collaborators

2 joint publications

Jinghui Zhang

2 joint publications

Gang Wu

2 joint publications

John T Lucas

2 joint publications

Amar Gajjar